LDL-Lowering Does Not Prevent CABG Graft Failure

Addition of the PCSK9 inhibitor evolocumab to statin therapy after CABG surgery does not improve 24-month graft patency, in the NEWTON-CABG CardioLink-5 trial.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/ldl-lowering-not-answer-cabg-graft-failure-2025a1000ok4?src=rss

Author :

Publish date : 2025-09-17 07:31:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

LDL-Lowering Does Not Prevent CABG Graft Failure

Higher VTE Risk in Patients With IBD After First CRC Surgery

NICE Recommends Durvalumab for Lung Cancer Patients

Related Posts

Amid Shutdown Fight, Healthcare Is One of the Most Intractable Issues in Congress

Canakinumab Better Than Anakinra in Treating VEXAS Syndrome

New Drug Approved for Deadly Lung Condition, First in Over a Decade

RFK Jr. ‘Endangering the Health of the Nation,’ Former Surgeons General Say

Medicaid Work Requirements Will Devastate People With Invisible Disabilities

Lifestyle May Preserve Bone Health in Seniors With Obesity

Amid Shutdown Fight, Healthcare Is One of the Most Intractable Issues in Congress

Canakinumab Better Than Anakinra in Treating VEXAS Syndrome

New Drug Approved for Deadly Lung Condition, First in Over a Decade

RFK Jr. ‘Endangering the Health of the Nation,’ Former Surgeons General Say

Medicaid Work Requirements Will Devastate People With Invisible Disabilities

Lifestyle May Preserve Bone Health in Seniors With Obesity

HRT May Get Revised Label; Costco to Sell No-Insurance Ozempic; CGM Without Diabetes

The Man Who Escaped Alzheimer’s; Shingles and Dementia; ALS Risk After Brain Injury

Categories

Archives